Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Silicon containing doai
Patent
1993-09-29
1996-05-07
Robinson, Allen J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Silicon containing doai
514184, 514185, A61K 31555, A61K 31695
Patent
active
055146694
ABSTRACT:
The present invention provides a method for diagnosing or treating prostatic tissue in a human or animal patient which comprises sensitizing the prostatic tissue with an effective amount of a photosensitive composition which accumulates in the prostatic tissue and exposing the sensitized tissue to a source of light energy for a predetermined time and intensity sufficient to cause cellular and/or tissue function of the sensitized prostatic tissue to diminish or cease.
REFERENCES:
patent: 4589404 (1986-05-01), Barath et al.
patent: 4740047 (1988-04-01), Abe et al.
patent: 4877872 (1989-10-01), Morgan et al.
patent: 4988808 (1991-01-01), Morgan et al.
patent: 5051415 (1991-09-01), Morgan et al.
patent: 5071416 (1991-12-01), Heller et al.
patent: 5116615 (1992-05-01), Gokcen et al.
patent: 5166197 (1992-11-01), Kenney et al.
patent: 5169395 (1992-12-01), Narciso, Jr.
patent: 5196005 (1993-03-01), Doiron et al.
patent: 5199950 (1993-04-01), Schmitt et al.
patent: 5216012 (1993-06-01), Morgan et al.
patent: 5231684 (1993-07-01), Narciso, Jr. et al.
patent: 5298018 (1994-03-01), Narciso, Jr.
patent: 5322507 (1994-06-01), Costello et al.
patent: 5330741 (1994-07-01), Smith et al.
Loh et al., Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract, J. Photochem. Photobiol., 20:47-54, 1993.
P. Sekher et al., Spectroscopic Studies of Tin Ethyl Etiopurpourin in Homogeneous and Heterogeneous Systems (1993), J. Photochem. Photobiol. B: Biol, 20:117-125.
International Search Report, Medical College of Ohio, PCT/US/94/07755, fld. 8 Jul. 1994.
Martinetto et al., Bactericidal Effects Induced By laser Irradiation and Haematoporphyrin Against Gran-Positive and Gran-Negative Microorganisms, Drugs Exp. Clin. Res. XII(4), 335-342, (1986).
Selman et al., Copper Benzochlorin A Novel Photosensitizer For Photodynamic Therapy: Effects On A Transplantable Urothelial Tumor, Photochem. and Photobiol., 57:681-685 (1993).
Morgan et al., Observations on the Synthesis and Spectroscopic Characteristics of Purpurins, J. Org. Chem. 51:1347-1350 (1986).
Skalkos et al., Iminium Salt Benzochlorins As Potential Photosensitizers In Photodynamic Therapy, Med. Chem. Res. 2:276-281 (1992).
Windahl et al., Photodynamic therapy of localised prostatic cancer, The Lancet 336:1139, (Nov. 3, 1990).
Selman et al., Normal Tissue effects of the metallopurpurin SnET2 and light. Proceedings of the International Society for Optical Engineering. SPIE 997:12-17, 1988.
Selman et al., Jejunal blood flow after exposure to light in rats injected with hematoporphyrin derivative. Cancer Res., 45:6425-6427, 1985.
Chaudhuri et al., Morphological changes of tumor microvasculature following hematoporphyrin derivative sensitized photodynamic therapy, Photochem. and Phtobiol., 46(5):823-827, 1987.
Selman et al., Hemodynamic effect of the metallopurpurin SnET2 and light on transplantable FANFT-induced tumors, J. Urology, 143:630-633, 1990.
Baert et al., Transuretharal microwave hyperthermia for benign prostatic hyperplasia: Preliminary clinical and pathological results, J. Urology, 144:1383-1387, 1990.
Cebulak Mary C.
Medical College of Ohio
Robinson Allen J.
LandOfFree
Use of photodynamic therapy to treat prostatic tissue does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of photodynamic therapy to treat prostatic tissue, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of photodynamic therapy to treat prostatic tissue will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1227338